United States· US:0591-4102_ac53b4c3-a05c-4ffc-a9ee-82bc1664fbc2
Perphenazine
A perphenazine product containing perphenazine, registered in United States by Actavis Pharma, Inc.. The same ATC class is registered in 9 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Perphenazine is registered in 9 of 19 countries.
Countries holding a registration under ATC N05AB03 (perphenazine), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 4 of them publish a price we can compare per daily dose
Perphenazine · ATC N05AB03
9 / 19 countries
- Canada
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Japan
- Norwayprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- PERPHENAZINE
- Manufacturer
- Actavis Pharma, Inc.
- Country
- United States (US)
- ATC code
- N05AB03
- ATC class
- Perphenazine
- Defined daily dose
- 30 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc110591410201100 TABLET, FILM COATED in 1 BOTTLE (0591-4102-01)
- ndc110591-4102-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
371 interactions on record for perphenazine.
Graded by severity as the source publishes them — 49 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Perphenazine · interactions on record
371 records
- 49 severe
- 285 moderate
- 11 minor
- 24 info
Most severe, free to view
- MetoclopramideA03FA01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- Potassium chlorideA12BA01severe
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Perphenazine in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayPeratsinOrion
- United KingdomFentazin 2mg tabletsAdvanz Pharma
- FinlandPeratsinOrion Corporation
- CanadaPERPHENAZINEAA PHARMA INC
- IcelandPeratsinOrion Corporation
- SpainDECENTAN 8 MG COMPRIMIDOSLaboratorios Ern S.A.
- GermanyPerphenazin NeuraxpharmNeuraxpharm Arzneimittel Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- Germany · Perphenazin Neuraxpharm
- Spain · Decentán
- Finland · Peratsin
- Iceland · Peratsin
- Italy · Trilafon
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f8cf9475-148a-46db-8928-29ef2253da51 GET /v1/drugs/f8cf9475-148a-46db-8928-29ef2253da51?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "4",
"substance": "PERPHENAZINE",
"productndc": "0591-4102",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA207582",
"marketing_category": "ANDA"
}See everything about perphenazine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.